ClinicalTrials.gg
Drug

ORM-12741 clinical trials

Also written ORM-12741.

studies test it
12
open now
0
in phase 3
0
first study started
2008

How each study uses ORM-12741 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ORM-12741 MR A
2
ORM-12741 MR B
2
ORM-12741 IR
2

Development codes

ORM-12741
10

Studies by the year they started

12 studies that test it; most in 2009 (4)

Studies that test ORM-12741, by start year
YearStudies
20082
20094
20101
20111
20142
20151
20181

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
9
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 1

Orion Corporation, Orion Pharma (11) · University of Cape Town (1)

Often tested with

Tested in the same studies.

ORM-14540 (1)

Studies

Open first, then newest update. How each study uses ORM-12741 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Codes

What other systems call ORM-12741 · ClinicalTrials.gg INT000014

  • Wikidata Q27276003orm-12741One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.